Jupiter Neurosciences, Inc.
JUNS
$0.34
-$0.01-3.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -94.13% | 7.55% | |||
| Gross Profit | 96.80% | -7.55% | |||
| SG&A Expenses | 87.97% | -1.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.22% | 1.42% | |||
| Operating Income | -22.28% | -1.42% | |||
| Income Before Tax | -12.54% | -1.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.54% | -1.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.54% | -1.55% | |||
| EBIT | -22.28% | -1.42% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -0.30% | 1.03% | |||
| Normalized Basic EPS | -11.43% | 0.94% | |||
| EPS Diluted | -0.89% | 4.00% | |||
| Normalized Diluted EPS | -11.43% | 0.94% | |||
| Average Basic Shares Outstanding | 12.16% | 2.59% | |||
| Average Diluted Shares Outstanding | 12.16% | 2.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||